Department of Internal Medicine I, University of Ulm, Ulm, Germany.
J Biol Chem. 2012 Mar 16;287(12):9473-83. doi: 10.1074/jbc.M112.339564. Epub 2012 Jan 6.
The members of the protein kinase D (PKD) family of serine/threonine kinases are major targets for tumor-promoting phorbol esters, G protein-coupled receptors, and activated protein kinase C isoforms (PKCs). The expanding list of cellular processes in which PKDs exert their function via phosphorylation of various substrates include proliferation, apoptosis, migration, angiogenesis, and vesicle trafficking. Therefore, identification of novel PKD substrates is necessary to understand the profound role of this kinase family in signal transduction. Here, we show that rhotekin, an effector of RhoA GTPase, is a novel substrate of PKD. We identified Ser-435 in rhotekin as the potential site targeted by PKD in vivo. Expression of a phosphomimetic S435E rhotekin mutant resulted in an increase of endogenous active RhoA GTPase levels. Phosphorylation of rhotekin by PKD2 modulates the anchoring of the RhoA in the plasma membrane. Consequently, the S435E rhotekin mutant displayed enhanced stress fiber formation when expressed in serum-starved fibroblasts. Our data thus identify a novel role of PKD as a regulator of RhoA activity and actin stress fiber formation through phosphorylation of rhotekin.
蛋白激酶 D(PKD)家族丝氨酸/苏氨酸激酶成员是肿瘤促进佛波酯、G 蛋白偶联受体和激活蛋白激酶 C 同工型(PKC)的主要靶标。PKD 通过磷酸化各种底物发挥作用的细胞过程不断增加,包括增殖、凋亡、迁移、血管生成和囊泡运输。因此,鉴定新的 PKD 底物对于了解该激酶家族在信号转导中的重要作用是必要的。在这里,我们表明 rho 激酶,RhoA GTPase 的效应物,是 PKD 的一个新底物。我们确定 rho 激酶中的丝氨酸 435 是 PKD 在体内靶向的潜在位点。表达磷酸模拟 S435E rho 激酶突变体导致内源性活性 RhoA GTPase 水平增加。PKD2 对 rho 激酶的磷酸化调节 RhoA 在质膜中的锚定。因此,当在血清饥饿的成纤维细胞中表达时,S435E rho 激酶突变体显示出增强的应力纤维形成。因此,我们的数据确定了 PKD 的一个新作用,即通过磷酸化 rho 激酶调节 RhoA 活性和肌动蛋白应力纤维形成。